Concepedia

Janet Johnson

JJ

Statistics

Publications

5

Citations

153

H-Index

5

Active since

1980

Affiliations

Supernus Pharmaceuticals (United States)(Current)

Janet Johnson is an author at Supernus Pharmaceuticals (United States) specializing in microbiology, biomanufacturing, and engineering.

Top concepts

Publications per year

1980–2019

5

Publications

5

A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD

Janet Johnson, Tesfaye Liranso, Keith E. Saylor et al. · Journal of Attention Disorders · 2019 · 60 citations · Full text

Efficacy and safety of extended‐release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial‐onset seizures: a randomized controlled trial

Jacqueline A. French, Paolo Baroldi, Scott Brittain et al. · Acta Neurologica Scandinavica · 2013 · 53 citations · Full text

Pharmacokinetic and Pharmacodynamic Evaluation of Atenolol during and after Pregnancy

Agneta K. Hurst, Avraham Shotan, Kristina Hoffman et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1998 · 19 citations

Liposomes replace serum for cultivation of fermenting mycoplasmas

R G Cluss, Janet Johnson, Norman L. Somerson · Applied and Environmental Microbiology · 1983 · 11 citations · Full text

, , +12

Cholesterol as a limiting factor in the growth of Mycoplasma pneumoniae

Janet Johnson, Norman L. Somerson · Applied and Environmental Microbiology · 1980 · 10 citations · Full text

1–5 of 5